Date | Title | Description |
17.05.2024 | Q4 results today: NHPC, ZEEL, Pfizer among 116 firms to post earnings today | - |
16.05.2024 | Myth or fact: Women feel the cold more than men | Some studies have revealed that a woman’s core body temperature is in fact slightly higher than a man’s. Image: Rawpixel
The fight between men and women over the office (or home) thermostat and what the optimal temperature should be is a we... |
14.05.2024 | Maryland's 2024 primary is Tuesday — Larry Hogan's candidacy makes Senate race uncommonly competitive | Washington — The winner of Maryland's Democratic Senate primary Tuesday is likely to face former Republican Gov. Larry Hogan for the open seat in a race that could tip the balance of power in the Senate.
Rep. David Trone and Prince George's... |
14.05.2024 | Which large-cap stocks did mutual funds buy and sell the most in April? | - |
13.05.2024 | Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting | 16 abstracts feature new data and post-hoc analyses of pivotal trials across several types of hard-to-treat cancers
TOKYO, May 13, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas")... |
13.05.2024 | France gets $16 billion of foreign investments as part of 'Choose France' event | EuropeFrance gets $16 billion of foreign investments as part of 'Choose France' event
By ReutersMay 13, 20244:46 AM UTCUpdated ago
Save
Text
Small Text
Medium Text
Large Text
Share
Twitter
Facebook
Linkedin
Email
Link
French President Emman... |
12.05.2024 | Pfizer и AstraZeneca инвестируют около $1 млрд во Францию | - |
10.05.2024 | "FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about them so far. | More than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing member of a group of so-called "FLiRT" variants, nicknamed for their small but distinctive changes relative to the JN.1 strain. JN.1 ... |
10.05.2024 | Nations struggle to draft pandemic treaty to avoid mistakes made in Covid | - |
10.05.2024 | Pfizer reaches settlement in over 10,000 cancer lawsuits related to Zantac | - |
10.05.2024 | Novavax strikes $1.2 billion deal with Sanofi in major turnaround | figcaption>span]:font-sans">
The French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing agreement worth as much as $1.2 billion that includes selling a combination COVID-flu shot.
Why it matt... |
09.05.2024 | Covishield side effects: Doctors' group urges to review all Covid vaccines | - |
09.05.2024 | WeAre8 scales transformational ad-experience across USA's biggest publishers | NEW YORK, May 9, 2024 /PRNewswire/ -- WeAre8, the revolutionary social technology platform, has today announced a collaboration with Public Good, America's leading digital purpose marketing solution. The partnership expands WeAre8's 'Golden... |
08.05.2024 | Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors | MARLBOROUGH, Mass., May 8, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immediately.
Dr. Pegus has more than 25 years of clinical and bu... |
08.05.2024 | Inflation 'settling' high could pose new risks for US Fed, economy | - |
08.05.2024 | Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Macau | SHANGHAI, May 8, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative me... |
08.05.2024 | Pfizer Receives Authorization from Health Authority for the First Dual Indication Vaccine Approved in Hong Kong | A Vaccine to Fight Against Respiratory Syncytial Virus (RSV) in Older Adults Aged 60 and Above and Infants (Through Maternal Immunization)
The first and only bivalent, single-dose vaccine that fights against both RSV A and RSV B disease thr... |
08.05.2024 | Pfizer Settles Over 10,000 Zantac Cancer Risk Lawsuits, Largest Deal Yet | John Lopez, Tech Times 08 May 2024, 12:05 pm
Pfizer has reached a major settlement in a legal battle concerning its recalled heartburn medication, Zantac.
According to a Bloomberg report, Pfizer has agreed to settle over 10,000 lawsuits tha... |
07.05.2024 | Myrtelle to Host a Symposium on Canavan Disease Clinical Trial Updates and Future Directions for Oligodendrocyte Targeting AAVs at the American Society of Gene and Cell Therapy 27th Annual Meeting in ... | NEW YORK, May 7, 2024 /PRNewswire/ -- Myrtelle Inc. ("Myrtelle" or the "Company"), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, will host a symposi... |
06.05.2024 | CRISPR Gene Editing Shows Promise: Early Trial Improves Vision in Blind Children | Quincy Jon, Tech Times 06 May 2024, 07:05 pm
An early-stage clinical experiment published in the New England Journal of Medicine found that gene therapy can improve hereditary blindness.
Researchers from the Children's Hospital of Philadelp... |
06.05.2024 | How this baseball All-Star steps up to the plate when it comes to pneumococcal pneumonia | (BPT) - Professional baseball player JD Martinez is at increased risk for pneumococcal pneumonia because he has asthma, and he doesn’t want to let it stop him from taking his shot on — or off — the field. If you’re not familiar with it, pne... |
05.05.2024 | Business | Boulder life-sciences leaders: Pfizer’s exit means opportunity | Lefkoff listed “six identifiable spinoffs” since Pfizer bought Array, four of which are publicly traded companies. They’re all doing very well.
“That’s what you want to see in an ecosystem like ours,” he said. “Nobody leaves, nobody’s freak... |
04.05.2024 | Anthropic's Claude Teams and iOS App Revolutionize Enterprise AI Adoption | Anthropic is leading the charge in responsible AI integration for businesses. With the release of Claude Teams and the new iOS app, the company is making waves in the industry. Discover how these innovations are changing the game for enterp... |
03.05.2024 | Patients on hunt for diabetes, obesity and weight-loss drugs | - |
03.05.2024 | Dr Reddy's Laboratories launches generic anti-bacterial medication in US | - |
02.05.2024 | Viagra trademark exclusive property of Pfizer, rules Delhi High Court | - |
02.05.2024 | ThetaRay Co-founder Mark Gazit Appointed Executive Chairman of the Global Management of N.E.W.S.® | LAUSANNE, Switzerland, May 2, 2024 /PRNewswire/ -- The N.E.W.S.® company, a global leader in leadership and organizational navigation, headquartered in Switzerland and operating in over 40 countries, today announced that Mark Gazit, co-foun... |
01.05.2024 | Anthropic’s Claude Teams and iOS App: The secure, scalable solution for enterprise AI adoption | Discover how companies are responsibly integrating AI in production. This invite-only event in SF will explore the intersection of technology and business. Find out how you can attend here.
Anthropic, a startup at the forefront of developin... |
01.05.2024 | Amazon's AI Focus Fuels Profit Surge, AWS Growth Reaccelerates | Quincy Jon, Tech Times 01 May 2024, 10:05 am
Amazon reported strong first-quarter 2024 profits on Tuesday. AI and advertising sales drove revenues up.
The multinational technology firm announced first-quarter sales of $143.3 billion, up 13%... |
30.04.2024 | AstraZeneca vaccine: From its origin to side effects, all you need to know | - |
30.04.2024 | Covishield: AZ cites regulators’ view that benefits outweigh risk of ‘extremely rare potential side effects’ | A recent class-action suit in the United Kingdom has put the spotlight on the AstraZeneca-Oxford University combine’s Covid-19 vaccine, and the possible risk of TTS (thrombosis with thrombocytopenia syndrome) linked to this vaccine.
The mul... |
30.04.2024 | NIIMBL announces 63 students for the 2024 NIIMBL eXperience | NEWARK, Del., April 30, 2024 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 63 students from 41 academic institutions have been selected to take part in the 2024 NII... |
30.04.2024 | Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO) | SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for... |
28.04.2024 | Microsoft's AI Revolution Threatens Amazon's Cloud Dominance | Microsoft's strategic investments in artificial intelligence are positioning the tech giant to potentially overtake Amazon's cloud services dominance. As quarterly reports loom, analysts anticipate Microsoft's generative AI investments will... |
28.04.2024 | Economic Rollercoaster: US Business Activity Cools, Economic Growth Slows | In April, US business activity hit a 4-month low due to weaker demand, while economic growth in the first quarter slowed to a 2-year low with surging inflation. The economy is on a rollercoaster ride, facing challenges and uncertainties. |
28.04.2024 | Corporate earnings, Fed interest rate decision to drive markets: Analysts | - |
27.04.2024 | The Melanoma Research Foundation to host the DC Miles for Melanoma 5K | 2024 DC Miles for Melanoma 5K
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thr... |
27.04.2024 | India becoming attractive for clinical trials, says pharma industry leaders | - |
26.04.2024 | US economic growth in Jan-Mar slows to a 2-year low; inflation surges | - |
25.04.2024 | GlaxoSmithKline sues Pfizer, BioNTech over Covid-19 vaccine technology | - |
25.04.2024 | Microsoft Could Topple Amazon's Cloud Dominance, Thanks to AI | Aldohn Domingo, Tech Times 25 April 2024, 12:04 am
Microsoft could soon overtake Amazon's cloud services dominance as the tech giant only continues to build on its artificial intelligence-powered lead in the industry.
As reported by Reuters... |
24.04.2024 | График вакцинопрофанации | - |
24.04.2024 | Govt expands committee for drugs, medical devices pricing reforms | - |
24.04.2024 | Pharma exports rise around 10% to $27.9 billion, US biggest importer | - |
23.04.2024 | Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform | DRESDEN, Germany & LEXINGTON, Mass.--(BUSINESS WIRE)-- Seamless Therapeutics today announced the appointments of Albert Seymour, Ph.D., as its new President and Chief Executive Officer and Adam Rosenberg as Independent Chairman of the c... |
23.04.2024 | April business growth at near 14-year high on robust demand, show PMIs | - |
23.04.2024 | Business | Pfizer to shutter Boulder R&D operations | Pharmaceutical giant Pfizer Inc. (NYSE: PFE) will shut down its research and development facility in Boulder in the coming months.
The move, first reported by Endpoints News, will result in an undisclosed number of job cuts. The facility at... |
22.04.2024 | The Ritz-Carlton, Denver Expands Luxury Guest Experience with Noventri Digital Signage | The Exterior of The Ritz-Carlton Denver
The Ritz-Carlton, Denver has chosen Noventri, a leading provider of innovative digital signage solutions, to enhance its guest experience and streamline its communication efforts by providing state-of... |
21.04.2024 | HHCN engages with states to boost preventive care for treating Haemophilia | - |
18.04.2024 | Rosy Debuts New Content Focused on Menopause and Migraine Education | The Women's Health Platform Will Make Evidence-Based Resources More Accessible.
DALLAS, April 18, 2024 /PRNewswire-PRWeb/ -- Rosy, the Webby Award winning app-based platform that addresses common health concerns for women throughout their l... |
18.04.2024 | Nigeria: A Case for Effective Electronic Medical Records Culture in Nigeria | The relevance of electronic medical records in Nigeria cannot be over-emphasized. However, implementing a functional and effective EMR system requires a collaborative and multi-faceted approach that addresses legal, technological, cultural,... |
17.04.2024 | World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" | MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is "Equitable access for all: recognizing all bl... |
17.04.2024 | Путин: в мире высок риск возникновения новых эпидемий, особенно уязвима Африка | - |
17.04.2024 | Parent Project Muscular Dystrophy Celebrates 30th Anniversary with Launch of PPMD Together Meeting Series in Cincinnati, Ohio | PPMD Together: Cincinnati Marks Three Decades of PPMD's Impact and Mayor's Proclamation
Honors Founding President & CEO Pat Furlong's Dedication to the Duchenne Community
CINCINNATI, April 17, 2024 /PRNewswire/ -- Parent Project Muscula... |
16.04.2024 | Biden govt announces partnership with 50 nations to stifle future pandemics | - |
16.04.2024 | J&J Q1 results: Profit beats expectations on cancer drugs strength | - |
15.04.2024 | Women of Influence: Health Care 2024 – Ileana Hernandez | - |
15.04.2024 | Inflation could hamper 'soft landing' of global economy despite US growth | - |
12.04.2024 | Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M | Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M
Fri, Apr 12, 2024 07:30 CET Report this content
Skanska announces that Pfizer has reduced the scope of work on its 25,000 square-meter... |
12.04.2024 | Inside Andy Jassy's plan for Amazon in the generative AI era | Tech Inside Andy Jassy's plan for Amazon in the generative AI era
Dan DeFrancesco
2024-04-12T12:55:11Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envelope. It indicates the ability to... |
12.04.2024 | Kore.ai commences ‘Kore.ai Konversations 2024’ | Kore.ai, a leader in enterprise conversational and generative AI space, is proud to announce the commencement of ‘Kore.ai Konversations 2024’, its premier customer event showcasing the latest AI innovations and strategies for adopting AI re... |
11.04.2024 | Amazon CEO Remains Confident Amid AI Race: "Inventing the Future" | Aldohn Domingo, Tech Times 11 April 2024, 09:04 pm
Amazon is reassuring its shareholders in its annual shareholder letter, especially in the tech giant's place in the ongoing artificial intelligence race.
Although the market and consumers g... |
08.04.2024 | Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort | -- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralization titers to approximately 6,600 IU/mL (6.4-fold increase) and approximately 46,000 IU/mL (12-fold increase), respectively --
-- Preliminary Phase I data in target older... |
08.04.2024 | EmeritusDX Announces Launch of FDA Approved Therascreen BRAF and KRAS Tests, Expanding Molecular Testing Capabilities | Headquarters in Lake Forest, CA
The Launch Aligns with the Company's Commitment to Personalized Care and Expanding it's Companion Diagnostics Portfolio
LAKE FOREST, Calif., April 8, 2024 /PRNewswire-PRWeb/ -- EmeritusDX, a leading cancer di... |
04.04.2024 | Don't count us out yet, Novavax says | After losing out on the COVID-19 vaccine race, Novavax is hoping its experimental combo flu-COVID vaccine can help turn around its fortunes.
But it finds itself in a familiar position of playing catch-up.
Why it matters: A year after it war... |
28.03.2024 | Countdown to Crunch Time: How Early and Continual Regulatory Engagement Leads to Regulatory and Commercial Success, Upcoming Webinar Hosted by Xtalks | www.worldwide.com
In this free webinar, industry-leading regulators with extensive experience in both the biopharma and the CRO space engage in a not-to-be-missed, dynamic conversation. Participants will uncover vital strategies for navigat... |
27.03.2024 | Lynn Rogien named Vice President and Michigan Business Leader for Gilbane Building Company | Lynn Rogien, Vice President and Michigan Business Leader, Gilbane Building Company
36-year industry veteran and Michigan-native to lead and expand Gilbane's presence in Michigan
DETROIT, March 27, 2024 /PRNewswire-PRWeb/ -- Gilbane Building... |
22.03.2024 | Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001 | BOSTON and HANGZHOU and SHANGHAI, China, March 22, 2024 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, announced that it ha... |
21.03.2024 | Advances in Digitalization Presented at the 10th Annual Genedata Biopharma Partner Symposium | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system for achieving operational excellence in biopharma R&D.
Leading scientific, IT, and business innovators in the biopharma industry showca... |
21.03.2024 | 5 неочевидных нейросетей для оптимизации текстов на русском языке | Специалисты Precedence Research отметили, что на 2023 год объем мирового рынка ИИ оценивается в 538,13 млрд долларов. Но, с учетом прогнозируемого темпа роста в 19%, к 2032 году эта цифра может увеличиться до 2,575 триллионов.
Позитивную те... |
21.03.2024 | Pfizer продает акции британского производителя товаров для здоровья Haleon на сумму £2,8 млрд | Pfizer Inc. продала акции Haleon Plc, что стало первым шагом крупнейшего акционера британской компании по производству товаров для здоровья потребителей по сокращению своей доли в 32%.
Pfizer уже некоторое время заявляла, что намерена сокра... |
21.03.2024 | Congressional leaders sell $1.2T spending package to members before shutdown deadline | - |
19.03.2024 | Resistell’s convincing study results published in Nature Communications |
Antimicrobial resistance (AMR) is a major public health threat, reducing treatment options for infected patients. AMR is promoted by a lack of access to rapid antibiotic susceptibility tests (ASTs). Accelerated ASTs can identify effective ... |
18.03.2024 | Pandemic pact crunch time: Final treaty talks start to prevent future deaths | An international draft treaty aimed at bolstering readiness for the next pandemic enters a final round of scheduled negotiations Monday, with key disagreements remaining about how much knowledge and product drugmakers must share with the wo... |
16.03.2024 | COVID paved the way for a new vaccine era | The unprecedented success of the COVID-19 vaccines has elevated the mRNA platform and raised expectations the technology could soon be wielded against other infectious diseases.
The big picture: COVID is still the only disease for which any... |
15.03.2024 | Health | Why COVID patients who could most benefit from Paxlovid still aren’t getting it | Arthur Allen | KFF Health News (TNS)
Evangelical minister Eddie Hyatt believes in the healing power of prayer but “also the medical approach.” So on a February evening a week before scheduled prostate surgery, he had his sore throat checked... |
15.03.2024 | African Diaspora Network (ADN) Announces Pivotal Partnership with Prosper Africa to Strengthen Economic Ties Between Africa and the USA | Prosper Africa and ADN collaboration will debut at the upcoming African Diaspora Investment Symposium (ADIS24)
SILICON VALLEY, Calif., March 14, 2024 /PRNewswire-PRWeb/ — African Diaspora Network (ADN) announces a pivotal partnership with P... |
15.03.2024 | CStone Announces the Fifth Indication Approved for Sugemalimab in China as First-Line Treatment for Gastric Cancer | Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma.
This marks the 13th NDA approval obtained by CStone and sugemalimab's fifth indicatio... |
13.03.2024 | Pharmaceuticals Licensing Agreements Analysis Report 2024 with a Directory of Deals Signed Since 2019 | - |
13.03.2024 | Global Oncologists Market Report 2024: Precision Medicine and Therapeutic Advancements Drive Expansion to $22.72 Billion by 2028 | - |
13.03.2024 | Hormonal Contraceptive Market is Set to Achieve Staggering USD 33.8 billion Valuation by 2031 with 5.0% CAGR | Analysis by Transparency Market Research, Inc. | - |
13.03.2024 | The Rise of Patient-Centric Healthcare App Market: Booms Future of Healthcare | Growing CAGR of 37.2% | By technology, it is segmented into phone-based apps, web-based apps, and wearable patient centric apps.
PORTLAND, OREGON, UNITED STATES, March 13, 2024 /EINPresswire.com/ -- The Patient Centric Healthcare App Market is revolutionizing the ... |
13.03.2024 | Contraceptives Market Growth Soars: Aiming for $50.6 Billion by 2030 with 6.5% CAGR | AMR | Contraceptives Market Report
WILMINGTON, DELAWARE, UNITED STATES, March 13, 2024 /EINPresswire.com/ -- Allied Market Research has recently unveiled a research study titled "Contraceptives Market Outlook and Forecast 2020-2030." Th... |
13.03.2024 | Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update | On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024
Initiated enrollment in PIVOT-PO, a pivotal Phase 3 clinical trial of ora... |
13.03.2024 | Preventive Healthcare Technologies And Services Market Forecast 2024-2033 –Market Size, Drivers, Trends, And Competitors | Preventive Healthcare Technologies And Services Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033
The Business Research Company's Preventive Healthcare Technologies And Services Global Market Report 2024 – Marke... |
13.03.2024 | Robert Kennedy Jr. says he's seriously considering Jets QB Aaron Rodgers to be his running mate | News Robert Kennedy Jr. says he's seriously considering Jets QB Aaron Rodgers to be his running mate
Brent D. Griffiths
2024-03-12T22:04:59Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An... |
13.03.2024 | Pregabalin Market to Reach $2.2Billion Globally, By 2032 at 3% CAGR: Allied Market Research | - |
13.03.2024 | Anxiety Disorder Treatment Market Size and Share Analysis, Trends, Advancements, Growth Forecast, 2030 | Anxiety Disorder Treatment Market
Anxiety Disorder Treatment Market to Reach $15.89 Billion by 2030, driven by the increasing prevalence of anxiety disorders & advancements in treatment options
With increasing awareness, growing prevale... |
13.03.2024 | Top 7 Markets In Pharmaceuticals Industry – By The Business Research Company | - |
13.03.2024 | Chronic Myeloid Leukemia Treatment Market On A Growth Trajectory: Market Size To Reach $12 Billion By 2028 As Per The Business Research Company's Chronic Myeloid Leukemia Treatment Global Market Repor... | - |
13.03.2024 | Europe Pharmaceutical Suspension Market Report By Type, By Distribution Channel, By End User, By Indication (Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others) Forecast to 2030 | - |
13.03.2024 | После вмешательства генпрокурора РФ 68 южноуральцев обеспечены лекарствами | - |
12.03.2024 | Hemophilia Treatment Market Poised for Growth, Forecasts Indicate Strong Expansion by 2030 | - |
12.03.2024 | Global Retinoblastoma Treatment Market Set to Reach $4.20 Billion by 2034 with Steady Growth in Targeted Therapies and Gene Treatment | - |
12.03.2024 | Drug Discovery Market Size, Share And Growth Analysis For 2024-2033 | Drug Discovery Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
The Business Research Company’s Drug Discovery Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
It will grow to $192.2 billion in ... |
12.03.2024 | Biologics Market Size Expected to Reach USD 845.78 Billion by 2033 | - |
12.03.2024 | Opioid Use Disorder Market to Reach USD 6.15 Billion by 2030, Driven by Growing Focus on Addiction Treatment | Opioid Use Disorder (OUD) Market
Opioid Use Disorder Market Analysis, Industry Trends and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 12, 2024 /EINPresswire.com/ -- The global opioid use disorder market is experiencing significant gr... |
11.03.2024 | Nasal Vaccines Market Current Trends, Growth Factors, Development and Forecast 2031:AstraZeneca, BioNTech SE, Pfizer Inc | Nasal Vaccines Market 2024 BURLINGAME, CALIFORNIA, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- Coherent Market Insights has released a statistical report titled "Nasal Vaccines Market Recent Trends, In-depth Analysis, Size, and... |
11.03.2024 | FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead Plaintiff Deadline in Securities Class Action Lawsuit Filed Against BioNTech SE (BNTX) | RADNOR, Pa., March 11, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Centra... |
11.03.2024 | Global $111+ Billion Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis 2024-2034 - Rapid Growth in Exon-Skipping Therapies Reflects Precision Medical Interventions Fueled by R&D | - |